Literature DB >> 18480105

Muscarinic receptors mediate stimulation of collagen synthesis in human lung fibroblasts.

S Haag1, S Matthiesen, U R Juergens, K Racké.   

Abstract

Clinical observations indicate that in chronic obstructive pulmonary disease patients, the long-acting muscarinic antagonist tiotropium delays decline in airway function, suggesting that cholinergic mechanisms contribute to long-term structural changes. Human lung fibroblasts express muscarinic receptors and the present study aimed to explore their role in controlling collagen synthesis. MRC-5, HEL-299 and primary human lung fibroblasts (phLFb) were cultured. Incorporation of [(3)H]-proline into cellular proteins was determined as measure of collagen synthesis. In MRC-5 cells, the muscarinic agonist carbachol enhanced [(3)H]-proline incorporation in a concentration-dependent manner (effective concentration of 50%: 220 nM, increase at 10 microM by 40-55%, in a different series of experiments). Likewise, 10 microM oxotremorine caused an increase of approximately 65%. For comparison, transforming growth factor-beta1 (5 ng x mL(-1)) caused an increase of approximately 80%. Effects of carbachol on total [(3)H]-proline incorporation and collagenase-sensitive [(3)H]-proline fraction were similar. The effect of 10 microM carbachol was inhibited by tiotropium (inhibitory concentration of 50%: 110 pM), prevented by pertussis toxin and the mitogen-activated protein kinase inhibitor, PD 98059. Muscarinic agonists also enhanced [(3)H]-proline incorporation in a tiotropium-sensitive manner in HEL-299 cells and phLFb. In human lung fibroblasts, muscarinic receptors exert stimulatory effects on collagen synthesis. Prolonged blockade of muscarinic-induced collagen synthesis may contribute to reported beneficial long-term effects of anticholinergics in chronic obstructive pulmonary disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18480105     DOI: 10.1183/09031936.00129307

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  32 in total

Review 1.  Airway Innervation and Plasticity in Asthma.

Authors:  L E M Kistemaker; Y S Prakash
Journal:  Physiology (Bethesda)       Date:  2019-07-01

Review 2.  Asthma therapy and its effect on airway remodelling.

Authors:  Rachid Berair; Christopher E Brightling
Journal:  Drugs       Date:  2014-08       Impact factor: 9.546

3.  The β2-subtype of adrenoceptors mediates inhibition of pro-fibrotic events in human lung fibroblasts.

Authors:  F Lamyel; M Warnken-Uhlich; W K Seemann; K Mohr; E Kostenis; A S Ahmedat; M Smit; R Gosens; H Meurs; A Miller-Larsson; Kurt Racké
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-05-21       Impact factor: 3.000

4.  Pro-fibrotic processes in human lung fibroblasts are driven by an autocrine/paracrine endothelinergic system.

Authors:  A S Ahmedat; M Warnken; W K Seemann; K Mohr; E Kostenis; U R Juergens; K Racké
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

Review 5.  Long-acting muscarinic receptor antagonists for the treatment of chronic airway diseases.

Authors:  Khuder Alagha; Alain Palot; Tunde Sofalvi; Laurie Pahus; Marion Gouitaa; Celine Tummino; Stephanie Martinez; Denis Charpin; Arnaud Bourdin; Pascal Chanez
Journal:  Ther Adv Chronic Dis       Date:  2014-03       Impact factor: 5.091

Review 6.  G-Protein-Coupled Receptors in Heart Disease.

Authors:  Jialu Wang; Clarice Gareri; Howard A Rockman
Journal:  Circ Res       Date:  2018-08-31       Impact factor: 17.367

Review 7.  Influencing the decline of lung function in COPD: use of pharmacotherapy.

Authors:  Ekaterina S Gladysheva; Atul Malhotra; Robert L Owens
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-06-03

8.  Tiotropium bromide inhibits TGF-β-induced MMP production from lung fibroblasts by interfering with Smad and MAPK pathways in vitro.

Authors:  Kazuhito Asano; Yusuke Shikama; Naruo Shoji; Kojiro Hirano; Harumi Suzaki; Hiroaki Nakajima
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-09-07

Review 9.  Pulmonary fibroblasts, an emerging target for anti-obstructive drugs.

Authors:  Kurt Racké; Susanne Haag; Amit Bahulayan; Mareille Warnken
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-02-13       Impact factor: 3.000

Review 10.  Crosstalk between beta-2-adrenoceptor and muscarinic acetylcholine receptors in the airway.

Authors:  Tonio Pera; Raymond B Penn
Journal:  Curr Opin Pharmacol       Date:  2014-04-17       Impact factor: 5.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.